Infectivity of Marek's disease agent after different treatments used in vaccine production.
Kottaridis
S D
SD
Luginbuhl
R E
RE
Fredrickson
T N
TN
D000482:Allantois / Q000821:virology; D000818:Animals; D001681:Biological Assay / Q000662:veterinary; D001793:Blood Preservation / Q000379:methods / Q000662:veterinary; D002642:Chick Embryo; D002645:Chickens; D005612:Freeze Drying / Q000662:veterinary; D008381:Herpesvirus 2, Gallid / Q000276:immunology / Q000472:pathogenicity*; D008380:Marek Disease / Q000821:virology*; D014422:Turkeys; D014765:Viral Vaccines / Q000592:standards*; D014766:Viremia / Q000821:virology*
D014765:Viral Vaccines